Skip to main content
Swiss giant Novartis halts COVID-19 hydroxychloroquine study - Medical Xpress 22-Jun-2020
Swiss giant Novartis halts COVID-19 hydroxychloroquine study - Medical Xpress
Swiss pharmaceuticals giant Novartis has decided to halt a clinical trial of hydroxychloroquine as a treatment for COVID-19, citing problems in recruiting enough patients for the study of the controversial drug.
More...